Friday, May 20, 2022
HomeHealth LawMonth-to-month Spherical-Up of What to Learn on Pharma Legislation and Coverage

Month-to-month Spherical-Up of What to Learn on Pharma Legislation and Coverage


By Ameet Sarpatwari, Alexander Egilman, Aviva Wang, andAaron S. Kesselheim

Every month, members of the Program On Regulation, Therapeutics, And Legislation (PORTAL) evaluate the peer-reviewed medical literature to determine attention-grabbing empirical research, coverage analyses, and editorials on well being legislation and coverage points.

Under are the citations for papers recognized from the month of March. The choices function subjects starting from a dialogue of affected person help applications and the Anti-Kickback Statute, to an evaluation of the results of state opioid prescribing legal guidelines on using opioids and different ache therapies, to an analysis of the affiliation between regulatory drug security advisories and modifications in drug use. A full posting of abstracts/summaries of those articles could also be discovered on our web site.

  1. Bendicksen L, Kesselheim AS. Anticipated efficiencies, actual prices: Medicaid managed care organizations and the pharmacy profit. J Manag Care Spec Pharm. 2022 Mar;28(3):354-361.
  2. Dhruva SS, Darrow JJ, Kesselheim AS, Redberg RF. Methods to handle medication and units permitted primarily based on restricted proof: outcomes of a modified Delphi panel. Clin Pharmacol Ther. 2022 Mar 16. Epub forward of print.
  3. Hidano D, Dhruva SS, Redberg RF. US Meals and Drug Administration-mandated postmarketing research for high-risk cardiovascular units permitted 2015-2019. JAMA Intern Med. 2022 Mar 14:e220184. Epub forward of print.
  4. McGinty EE, Bicket MC, Seewald NJ, Stuart EA, Alexander GC, Barry CL, McCourt AD, Rutkow L. Results of state opioid prescribing legal guidelines on use of opioid and different ache therapies amongst commercially insured U.S. adults. Ann Intern Med. 2022 Mar 15. Epub forward of print.
  5. Morrow RL, Mintzes B, Souverein PC, De Bruin ML, Roughead EE, Lexchin J, Kemp-Casey A, Puil L, Sketris I, Mangin D, Hallgreen CE, Pearson SA, Lopert R, Bero L, Ofori-Asenso R, Gnjidic D, Sarpatwari A, Perry LT, Dormuth CR. Affect of drug security advisories on drug utilisation: a world interrupted time collection and meta-analysis. BMJ Qual Saf. 2022 Mar;31(3):179-190. Epub forward of print.
  6. Sinha MS, Kesselheim AS, Robertson CT. Affected person help applications and the Anti-Kickback Statute: charting a pathway ahead. 2022 Mar 10. Epub forward of print.
  7. Vokinger KN, Hwang TJ, Carl DL, Laube Y, Ludwig WD, Naci H, Kesselheim AS. Worth modifications and within-class competitors of most cancers medication within the USA and Europe: a comparative evaluation. Lancet Oncol. 2022 Apr;23(4):514-520. Epub forward of print.
  8. Woloshin S, Dewitt B, Krishnamurti T, Fischhoff B. Assessing how customers interpret and act on outcomes from at-home COVID-19 self-test kits: a randomized medical trial. JAMA Intern Med. 2022 Mar 1;182(3):332-341.

The publish Month-to-month Spherical-Up of What to Learn on Pharma Legislation and Coverage appeared first on Invoice of Well being.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -
Google search engine

Most Popular

Recent Comments